Evaluating how diet affects breast cancer risk

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the link between dietary inflammatory potential and the risk of breast cancer in women identified as high risk at the Ohio State University Comprehensive Cancer Center. Participants will complete a food frequency questionnaire to assess their dietary inflammatory potential, which will be monitored over time to observe any changes and their relationship to breast cancer incidence. The study also aims to correlate dietary patterns with obesity measures and mammographic breast density. By identifying modifiable dietary risk factors, the research seeks to enhance prevention strategies and early intervention for breast cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>= 18 years
* Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer \[BC\], known genetic predisposition, personal history of known atypia/breast lobular carcinoma in situ \[LCIS\], or prior chest wall radiation)
* Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS)
* Able to read and understand English
* Able to provide informed consent
* Must consent to continued follow-up of medical records during the study period

Exclusion Criteria:

* Prisoners
* Not able to speak and understand English
* Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC

Where it's running

• Ohio State University Comprehensive Cancer Center
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: Sagar D Sardesai, MSPH, PhD — Ohio State University Comprehensive Cancer Center
• Study coordinator: The Ohio State University Comprehensive Cancer Center
• Email: OSUCCCClinicaltrials@osumc.edu
• Phone: 800-293-5066

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Finding the best dose of tamoxifen to reduce breast cancer risk in premenopausal women

  This study is testing if a higher dose of tamoxifen can help premenopausal women at higher risk for breast cancer by reducing breast density on mammograms.

  Recruiting at 10 sites Phase 2 National Cancer Institute (NCI) · Tucson, Arizona and 10 other locations · NCT06184750

• Using low dose tamoxifen with or without omega-3 fatty acids to reduce breast cancer risk

  This study is testing whether adding omega-3 fatty acids to low dose tamoxifen can help reduce the risk of breast cancer in overweight or obese postmenopausal women.

  Recruiting at 3 sites Phase 2 National Cancer Institute (NCI) · Kansas City, Kansas and 2 other locations · NCT06195306

• Comparing acolbifene and low dose tamoxifen to prevent breast cancer in high-risk premenopausal women

  This study is testing whether acolbifene or low dose tamoxifen can help prevent breast cancer in high-risk premenopausal women.

  Recruiting at 4 sites Phase 2 National Cancer Institute (NCI) · Duarte, California and 3 other locations · NCT05941520

• Mobile health navigation to improve breast cancer screening in Kenyan women

  This study tests m-Health patient navigation tools to help women in Kenya access breast cancer screening and early detection services.

  Recruiting Emory University · Atlanta, Georgia · NCT07764796

• Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression

  This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.

  Recruiting at 11 sites City of Hope Medical Center · Arcadia, California and 10 other locations · NCT07741968

• Environmental exposure checks in high-risk and early-onset breast cancer care

  This study tests how patients and providers feel about using environmental exposure risk data in breast cancer care for women at average/high risk or with early-onset breast cancer.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07690852

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.